Hypothyroidism and AMH in Iraqi Patients with Chronic Kidney Disease

Authors

Noori M. Luaibi, Biology Department, College of Science, Mustansiriyah University, Baghdad, Iraq.Follow
Athraa K. Falhi, Biology Department, College of Science, Mustansiriyah University, Baghdad, Iraq.Follow
Ali J. Alsaedi, Consultant Nephrologist, Medical City, Baghdad, Iraq.Follow

Abstract

This study was conducted to investigate thyroid function and Anti-Müllerian hormone (AMH) in (Chronic kidney disease) CKD patients by evaluating their levels in CKD patients, 50 patients were diagnosed to have CKD stage-5, their ages ranged between 20-50 years (25 males and 25 females) who attended the Nephrology and Transplant Center in Medical City of Baghdad- Iraq, they were recruited from April 2018 to July 2018 and were enrolled into the study. The control group consisted of 20 healthy individuals, their ages ranged between 20-48 years (10 males and 10 females). The study showed non-significant (p>0.05) increase in AMH level in CKD patients compared to the control group. On the other hand, TSH was recorded a highly significant (P<0.01) increase in CKD patients in comparison with control. While T3 and T4 levels recorded highly significant (P<0.01) decrease in CKD patients in comparison with control.

Keywords

CKD, Hypothyroidism, TSH, T3, AMH.

Article Type

Supplemental Issue

How to Cite this Article

Luaibi, Noori M.; Falhi, Athraa K.; and Alsaedi, Ali J. (2021) "Hypothyroidism and AMH in Iraqi Patients with Chronic Kidney Disease," Baghdad Science Journal: Vol. 18: Iss. 1, Article 34.
DOI: https://doi.org/10.21123/bsj.2021.18.1(Suppl.).0695